STE
Medical Devices · Healthcare
CEO, Board Member
2021-01-29–present
CEO
STERIS plc (STE)Board Member
STERIS plc (STE)Equibles does not estimate personal net worth.
Get an email with a short summary when STERIS plc publishes a filing, an earnings call transcript or a press release.
Get STE alertsDaniel A. Carestio is recorded as Board Member at STERIS plc (STE) since January 29, 2021 and CEO at STERIS plc (STE). The proxy statement of STERIS plc reports total compensation of $11,508,522 for Daniel A. Carestio in fiscal 2026, including a base salary of $1,095,707. Disclosed compensation is on record for 9 fiscal years. Daniel A. Carestio has spoken on 6 earnings calls and 1 other investor event across 1 company, most recently for STERIS plc on September 15, 2026. STERIS plc is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at STERIS plc includes J. Adam Zangerle (General Counsel), ANNUAL REPORT (Board Member), APPENDIX A (Board Member) and 7 others.
“You know, I think the one thing that I would really point to is how resilient and how durable the demand is for our products and services, in particular in the health care space.”
“Thank you for joining us to hear more about our first quarter of 2027 performance and our outlook for the remainder of the year. Karen covered the quarter at a high level, so I will add some commentary on our segments.”
“Karen covered the quarter at a high level, so I will add some commentary on the segments. Starting with Healthcare. Constant currency organic revenue grew 9% in the second quarter, with growth across all categories.”
“Thank you for making time to join us to hear more about our first quarter performance and our outlook for the rest of the fiscal year. As you heard from Mike, we had a strong start to our new fiscal year exceeding our plans and STERIS' expectations.”
“I will cover a few of the highlights of the year and then address our outlook for fiscal 2024. As you heard from Mike, we ended the year strong and grew revenue 9% on a constant currency organic basis in fiscal 2023.”
2021-01-29–present
STE
Medical Devices · Healthcare
CEO, Board Member
2021-01-29–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2026 | STERIS plc (STE) | President and CEO | $1,095,707 | $11,508,522 |
| 2025 | STERIS plc (STE) | President and CEO | $1,063,860 | $10,673,062 |
| 2024 | STERIS plc (STE) | President and CEO | $1,030,600 | $9,550,776 |
| 2023 | STERIS plc (STE) | President and CEO | $969,862 | $7,740,184 |
| 2022 | STERIS plc (STE) | President and CEO | $767,280 | $5,903,168 |
| 2021 | STERIS plc (STE) | President and CEO | $542,385 | $2,912,769 |
| 2020 | STERIS plc (STE) | President and CEO | $521,750 | $2,425,842 |
| 2019 | STERIS plc (STE) | Senior Vice President and Chief Operating Officer | $481,731 | $2,146,642 |
| 2018 | STERIS plc (STE) | Senior Vice President and Chief Operating Officer | $378,558 | $1,325,771 |